| |
| |
|
| Insider
Information: |
Crowley John F |
| Relationship: |
Director |
| City: |
Cranbury |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
590,194 |
|
|
Indirect Shares
|
97,759 |
|
|
| Direct
Value |
$6,335,090 |
|
|
|
Indirect Value
|
$688,536 |
|
|
| Total
Shares |
687,953 |
|
|
| Total
Value |
$7,023,626 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amicus Therapeutics Inc |
FOLD |
|
2024-03-01 |
573,478 |
2024-03-01 |
64,895 |
Premium* |
|
|
Intellia Therapeutics, Inc. |
NTLA |
Director |
2023-06-14 |
11,716 |
2021-06-23 |
0 |
Premium* |
|
|
Entrada Therapeutics, Inc. |
TRDA |
Director |
2022-01-12 |
5,000 |
2022-01-12 |
32,864 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
298 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 9 of 12
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2021-06-07 |
4 |
AS |
$10.01 |
$295,192 |
D/D |
(29,500) |
877,230 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2021-06-15 |
4 |
AS |
$10.26 |
$225,632 |
D/D |
(22,000) |
877,230 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2021-06-15 |
4 |
OE |
$4.38 |
$96,360 |
D/D |
22,000 |
899,230 |
0 |
- |
|
| NTLA |
Intellia Therapeutics, In... |
Director |
– • – |
2021-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
2,094 |
2,094 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2021-07-12 |
4 |
AS |
$9.31 |
$138,652 |
D/D |
(14,885) |
862,345 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2021-08-05 |
4 |
AS |
$10.03 |
$371,047 |
D/D |
(37,000) |
847,345 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2021-08-05 |
4 |
OE |
$4.38 |
$96,360 |
D/D |
22,000 |
884,345 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2021-08-16 |
4 |
OE |
$4.38 |
$96,360 |
D/D |
22,000 |
869,345 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2021-08-16 |
4 |
AS |
$10.27 |
$225,918 |
D/D |
(22,000) |
847,345 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2021-09-01 |
4 |
AS |
$11.50 |
$86,250 |
D/D |
(7,500) |
839,845 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2021-09-03 |
4 |
AS |
$12.02 |
$62,944 |
D/D |
(5,238) |
839,845 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2021-09-03 |
4 |
OE |
$3.53 |
$19,563 |
D/D |
5,238 |
845,083 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2021-09-15 |
4 |
OE |
$4.38 |
$96,360 |
D/D |
22,000 |
861,845 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2021-09-15 |
4 |
AS |
$11.08 |
$243,828 |
D/D |
(22,000) |
839,845 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2021-10-01 |
4 |
AS |
$10.00 |
$75,000 |
D/D |
(7,500) |
832,345 |
0 |
- |
|
| NTLA |
Intellia Therapeutics, In... |
Director |
– • – |
2021-10-05 |
4 |
AS |
$128.83 |
$1,305,391 |
D/D |
(10,000) |
2,094 |
0 |
% |
|
| NTLA |
Intellia Therapeutics, In... |
Director |
– • – |
2021-10-05 |
4 |
OE |
$18.83 |
$188,300 |
D/D |
10,000 |
12,094 |
0 |
- |
|
| NTLA |
Intellia Therapeutics, In... |
Director |
– • – |
2021-10-11 |
4 |
OE |
$18.83 |
$47,075 |
D/D |
2,500 |
4,594 |
0 |
- |
|
| NTLA |
Intellia Therapeutics, In... |
Director |
– • – |
2021-10-11 |
4 |
AS |
$119.55 |
$298,875 |
D/D |
(2,500) |
2,094 |
0 |
% |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2021-10-15 |
4 |
OE |
$4.38 |
$96,360 |
D/D |
22,000 |
854,345 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2021-10-15 |
4 |
AS |
$11.22 |
$246,871 |
D/D |
(22,000) |
832,345 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Director |
– • – |
2021-10-28 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
32,864 |
|
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2021-11-01 |
4 |
AS |
$10.80 |
$84,451 |
D/D |
(7,819) |
824,526 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2021-11-03 |
4 |
AS |
$12.00 |
$332,868 |
D/D |
(27,739) |
824,526 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2021-11-03 |
4 |
OE |
$3.82 |
$105,963 |
D/D |
27,739 |
852,265 |
0 |
- |
|
298 Records found
|
|
Page 9 of 12 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
